Thermedical Awarded $3 Million NIH Grant to Study Promising Treatment for Ventricular Tachycardia, a Leading Cause of Sudden Cardiac Death
Summary
WALTHAM, Mass.--(BUSINESS WIRE)-- Thermedical\xae, a developer of thermal-ablation systems to treat ventricular arrhythmias, announced today it has received $3 million in grant funding (1R44HL169112) from the National Heart, Lung, and Blood Institute, a part of the National Institutes of Health, to fund its FDA-approved clinical trial at seven centers in the U.S. and Canada using the SERF Ablation System with the Durablate\xae Catheter to treat ventricular tachycardia (VT). Sudden cardiac death kills 325,000 adults in the U.S. every year1.The company also announced it will showcase its novel Saline Enhanced Radiofrequency (SERF) Ablation System with the Durablate Catheter at the 18th Annual International Symposium on Ventricular Arrhythmias: Pathophysiology & Therapy, October 1314, 2023, at the Bellevue Hotel Philadelphia.We are honored to receive this generous grant from the NIH to fund the treatment of VT using our SERF Ablation System in patients who have run out of treatment options for their VT episodes, said Michael Curley, Ph.D., FHRS, co-founder and CEO of Thermedical. In our most recent multi-center trial, 38 of 41 participants experienced immediate elimination of their clinical VT at the end of the procedure, and therapies such as shock or pace regulation were either substantially reduced or completely eliminated in 73% of these patients during the six-month follow-up.SERF ablation with the Durablate catheter is being evaluated as a treatment option for patients with ventricular arrhythmias resistant to antiarrhythmic drugs or standard ablation procedures. The Durablate catheter delivers energy with a high level of accuracy to treat tissue deeper in the heart wall where life-threatening arrhythmias that cause VT are often located. "Episodes of ventricular tachycardia reduce the quality of life for many patients with implantable defibrillators," said William G. Stevenson, Professor of Medicine, Vanderbilt University Medical Center.